The Public University of Navarre spinout will use the funds to prepare clinical trials of its biomarker-based asthma diagnosis device.

Eversens, a Spain-based asthma technology developer spun out from Public University of Navarre, has raised €660,000 ($765,000) in a round led by government-backed tech transfer fund UN I+D+i Technology Transfer.

UN I+D+i, which primarily invests in University of Navarra technologies, committed €330,000 to the round, while VC firm Startup Capital Navarra supplied €230,000. Sodena, a regional government-owned development agency, has provided an equity loan of €100,000.

Eversens named UN I+D+i and Sodena as existing shareholders, but further details have not…